Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.3144
-0.0073 (-2.27%)
At close: Oct 9, 2026, 4:00 PM EDT
0.3108
-0.0036 (-1.15%)
After-hours: Oct 9, 2026, 7:59 PM EDT
SNTI Market Cap
SNTI has a market cap or net worth of $9.79 million as of October 9, 2026. It is the 41,789th most valuable company in the world and the 5,657th biggest in the United States. Its market cap has decreased by 78.97% in one year.
Market Cap
9.79M
Enterprise Value
23.41M
1-Year Change
-78.97%
Global Rank
Country Rank
#5,657 United States
Category
ChartMarket Cap Chart
Since May 26, 2021, SNTI's market cap has decreased from $256.04M to $9.79M, a decrease of -96.18%. That is a compound annual growth rate of -45.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 9.79M | -64.19% |
| Dec 31, 2025 | 27.34M | 69.76% |
| Dec 31, 2024 | 16.11M | -45.22% |
| Dec 29, 2023 | 29.40M | -52.46% |
| Dec 30, 2022 | 61.84M | -78.72% |
| Dec 31, 2021 | 290.53M | 13.47% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 10.93M |
| Lisata Therapeutics | 10.81M |
| GT Biopharma | 10.75M |
| Lantern Pharma | 10.61M |
| Purple Biotech | 10.54M |
| Adial Pharmaceuticals | 10.42M |
| Theriva Biologics | 10.42M |
| Immuron | 10.11M |